ConductScience.org, home

Paper · 7002129

The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.

Wilson WR and 2 others. Arch Otolaryngol, 1980. Cited by 699 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Papers, record 7002129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7002129

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study.
PubMed
Journal
Arch Otolaryngol
PubMed
Year
1980
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
699
iCite
Relative citation ratio, by iCite
34.8
iCite
Revised in PubMed
2022-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilson WRW R
2Byl FMF M
3Laird NN

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucocorticoidsMajor topic
Hearing Loss, SensorineuralMajor topic
Adult
Age Factors
Clinical Trials as Topic
Dexamethasone
Double-Blind Method
Humans
Methylprednisolone
Placebos

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NS 15629NINDS NIH HHSUnited StatesR01NS015629PubMed and NIH

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT07134075Intracochlear Injection of GlucocorticoidBackgroundClinicalTrials.gov
NCT07540728Trans-round Window Membrane Intracochlear SteroidBackgroundClinicalTrials.gov
NCT07814677Efficacy and Safety of Intracochlear Injection of Glucocorticoid Through the Round Window Membrane in Patients With Profound or Complete Sudden Sensorineural Hearing LossBackgroundClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by217

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 699 citations.

PMIDTitleJournalYearIn PapersSource
42,982,521Study protocol of the SuDHO study: hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomised controlled trial.BMJ Open2026https://conductscience.org/library/papers/42982521PubMed
42,746,638Sensorineural Hearing Loss and Phosphodiesterase-5 Inhibitors: A Systematic Review.Int Arch Otorhinolaryngol2026https://conductscience.org/library/papers/42746638PubMed
42,543,415Differentiating hidden meniere's disease from typical sudden sensorineural hearing loss: clinical significance of acute low-tone hearing loss.Eur Arch Otorhinolaryngol2026https://conductscience.org/library/papers/42543415PubMed
42,383,431Optimal Timing of Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss: A Mini-Review.Medeni Med J2026https://conductscience.org/library/papers/42383431PubMed
42,230,800Semicircular canal dysfunction in profound sudden sensorineural hearing loss and its prognostic value: implications for the proper indication of hyperbaric oxygen therapy.Sci Rep2026https://conductscience.org/library/papers/42230800PubMed
41,948,607Seasonal effects on incidence and outcomes in idiopathic sudden sensorineural hearing loss.Front Neurol2026https://conductscience.org/library/papers/41948607PubMed
41,567,673Relationship between different blood routine parameters and different types of sudden deafness and prognosis.Front Med (Lausanne)2025https://conductscience.org/library/papers/41567673PubMed
41,327,826Harnessing Machine Learning for Personalized Care of Patients With Idiopathic Sudden Sensorineural Hearing Loss: A Multicenter Cohort Study.Clin Exp Otorhinolaryngol2026https://conductscience.org/library/papers/41327826PubMed
41,312,345Several proteins derived from serum exosomes are potential biomarkers for diagnosis and progression of sudden sensorineural hearing loss.Front Neurol2025https://conductscience.org/library/papers/41312345PubMed
40,994,247A novel audiogram model for predicting the prognosis of sudden sensorineural hearing loss.J Chin Med Assoc2025https://conductscience.org/library/papers/40994247PubMed

1 to 10 of 217

See all 217 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7002129

GET https://conductscience.org/api/papers/v1/7002129/cited_by?page=2